Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,450 | -13,690 | -8,150 | 5,620 | 21,490 |
| Depreciation Amortization | 1,500 | 1,150 | 580 | 2,130 | 1,250 |
| Other Working Capital | 10,720 | 9,070 | 5,360 | 5,510 | -7,210 |
| Other Operating Activity | 6,330 | 1,220 | 1,420 | 7,150 | 5,560 |
| Operating Cash Flow | $-900 | $-2,250 | $-790 | $20,410 | $21,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -390 | -220 | -130 | -1,240 | -830 |
| Net Acquisitions | -40 | -460 | 0 | -770 | 0 |
| Other Investing Activity | -38,940 | -26,510 | -27,970 | 12,670 | -39,970 |
| Investing Cash Flow | $-39,370 | $-27,190 | $-28,100 | $10,660 | $-40,800 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 190 | 1 | 1 | -1,330 | -1,920 |
| Financing Cash Flow | $190 | $1 | $1 | $-1,330 | $-1,920 |
| Beginning Cash Position | 72,360 | 72,360 | 72,360 | 42,620 | 42,620 |
| End Cash Position | 32,280 | 42,920 | 43,460 | 72,360 | 20,990 |
| Net Cash Flow | $-40,080 | $-29,440 | $-28,900 | $29,740 | $-21,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -900 | -2,250 | -790 | 20,410 | 21,090 |
| Free Cash Flow | -900 | -2,250 | -790 | 20,410 | 21,090 |